Sign in

NCT06674499Completed

Development and Evaluation of a Self-Management Model for Cancer Rehabilitation

A Randomized Controlled Clinical Trial on the Development and Evaluation of a Self-Management Model for Cancer Rehabilitation

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

Participants were primarily recruited from medical institutions, specifically targeting newly diagnosed patients with malignant tumors. They were randomly assigned to two different rehabilitation models using block randomization: the cancer self-help rehabilitation model or the conventional rehabilitation model. During the intervention period, trained oncology advanced practice nurses conducted weekly questionnaire surveys for enrolled patients. During the follow-up period, these surveys were conducted every four weeks. Peripheral venous blood samples were collected at baseline and radiotherapy completion to test for biomarkers related to emotional distress.

Status (registry)
Completed
Study type
Interventional
Enrollment
144 (actual)
First submitted
28 Oct 2024
Start date
1 Dec 2024
Primary completion date
31 Jan 2026
Lead sponsor
Xingchen Peng
NCT number
NCT06674499

What you commit to

  • Study type: Interventional
  • Participants enrolled: 144
  • From 1 Dec 2024 to the primary completion date, 31 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients currently receiving other psychological treatments or taking psychiatric medications.

Other illness

  • A history of other malignancies within the past 5 years.
  • A history of any mental illness, including but not limited to: generalized anxiety disorder, depressive disorder, panic disorder, schizophrenia, or bipolar disorder.

Who the study is looking for

  • Pathologically diagnosed with head and neck malignancy.
  • Experiencing psychological distress.
  • Aged between 18 and 70 years.
  • Patients scheduled to receive antitumor treatment in a day hospital or outpatient setting.
  • ECOG performance status score of 0-2.
  • Patients voluntarily participate, fully understand, and are able to independently complete the questionnaires.

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
WestChina Hospital
Coordinator of this site? Confirm its status
ChengduChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.